Evidence map›Paper›PMID 40567746›Full record

ArticlePeerJ. Computer science2025

Hyperdimensional computing in biomedical sciences: a brief review.

Fabio Cumbo, Davide Chicco

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fabio Cumbo *Center for Computational Life Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States.ORCID 0000-0003-2920-5838
Davide Chicco *Dipartimento di Informatica Sistemistica e Comunicazione, Università di Milano-Bicocca, Milan, Italy.ORCID 0000-0001-9655-7142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperdimensional computing (HDC, also known as vector-symbolic architectures-VSA) is an emerging computational paradigm that relies on dealing with vectors in a high-dimensional space to represent and combine every kind of information. It finds applications in a wide array of fields including bioinformatics, natural language processing, machine learning, artificial intelligence, and many other scientific disciplines. Here we introduced the basic foundations of the HDC, focusing on its application to biomedical sciences, with a particular emphasis to bioinformatics, cheminformatics, and medical informatics, providing a critical and comprehensive review of the current HDC landscape, highlighting pros and cons of applying this computational paradigm in these specific scientific domains. In this study, we first selected around forty scientific articles on hyperdimensional computing applied to biomedical data existing in the literature, and then analyzed key aspects of their studies, such as vector construction, data encoding, programming language employed, and other features. We also counted how many of these scientific articles are open access, how many have public software code available, how many groups of authors, journals, and conferences are most present among them. Finally, we discussed the advantages and limitations of the HDC approach, outlining potential future directions and open challenges for the adoption of HDC in biomedical sciences. To the best of our knowledge, our review is the first open brief survey on this topic among the biomedical sciences, and therefore we believe it can be of interest and useful for the readership.

Indexed as

BioinformaticsBiomedical sciencesCheminformaticsHyperdimensional computingMedical informaticsReviewVector-symbolic architectures

Identifiers

PMID40567746
PMCPMC12192801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.